A lack of finance for black investors is holding up Bidvest’s aggressive and serious attempts to dispose of its 38.5% interest in JSE-listed pharmaceutical firm Adcock Ingram, says Bidvest CEO Lindsay Ralphs. Bidvest’s preferred deal would give black investors a substantial stake in a well-established company that is set for growth, especially after Adcock’s recent acquisition of surgical and skincare products supplier Genop. Adcock’s fortunes were turned around after Bidvest bought the stake in 2014, replaced the management and restructured operations. The stake in Adcock, valued at R4.8bn at the current share price, is among assets that Bidvest wants to sell in order to focus on its core divisions. Speaking after the release of the company’s results for the year to end-June, Ralphs said Bidvest had struggled to sell the stake to black investors because of a lack of finance. "We have really attempted aggressively and seriously to dispose of [the Adcock stake] over the last two year...

BL Premium

This article is reserved for our subscribers.

A subscription helps you enjoy the best of our business content every day along with benefits such as exclusive Financial Times articles, ProfileData financial data, and digital access to the Sunday Times and Times Select.

Already subscribed? Simply sign in below.

Questions or problems? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now